Reduction in Symptoms for Homebound Patients Receiving Home-Based Primary and Palliative Care
To cite this article:Katherine Ornstein, Ania Wajnberg, Halley Kaye-Kauderer, Gary Winkel, Linda DeCherrie, Meng Zhang, and Theresa Soriano. Journal of Palliative Medicine. September 2013, 16(9): 1048-1054. doi:10.1089/jpm.2012.0546.
Published in Volume: 16 Issue 9: September 16, 2013
Online Ahead of Print: June 8, 2013
Online Ahead of Print: June 8, 2013
Author information
Katherine Ornstein, PhD, MPH,1 Ania Wajnberg, MD,2 Halley Kaye-Kauderer,3 Gary Winkel, PhD,4 Linda DeCherrie, MD,1 Meng Zhang, MD,2 and Theresa Soriano, MD, MPH2
1Department of Geriatrics and Palliative Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
2The Samuel Bronfman Department of Medicine, Division of General Internal Medicine, Icahn School of Medicine at Mount Sinai, New York, New York.
3Yale University, New Haven, Connecticut.
4Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York.
Accepted April 11, 2013
ABSTRACT
Background:
Increasing numbers of patients are living with multiple, chronic
medical conditions and functional impairments that leave them homebound.
Home-based primary and palliative care (HBPC) programs provide access
to health care services for this vulnerable population. Homebound
patients have high symptom burden upon program enrollment. Yet little is
known as to how individual symptoms are managed at home, especially
over longer time periods.
Objectives: The purpose of this study was to determine whether high symptom burden decreases following HBPC enrollment.
Methods:
All patients newly enrolled in an HBPC program who reported at least
one symptom on the Edmonton Symptom Assessment Scale (ESAS) were
eligible for telephone ESAS follow-up. Patients received a comprehensive
initial home visit and assessment by a physician with subsequent
follow-up care, interdisciplinary care management including social work,
and urgent in-home care as necessary. Multivariate linear mixed models
with repeated measures were used to assess the impact of HBPC on pain,
depression, anxiety, tiredness, and loss of appetite among patients with
moderate to severe symptom levels at baseline.
Results:
One hundred forty patients were followed. Patient pain, anxiety,
depression, and tiredness significantly decreased following intervention
with symptom reductions seen at 3 weeks and maintained at 12 weeks. (p<0.01)
Loss of appetite trended toward an overall significant decrease and
showed significant reductions at 12 week follow-up.
Conclusion:
In a chronically ill population of urban homebound, patient symptoms
can be successfully managed in the home.
Future work should continue to
explore symptom assessment and management over time for the chronically
ill homebound.
No comments:
Post a Comment